ESTRO-ESSO-ESMO Evidence and New Challenges in Rectal Cancer

7 - 10 October 2012, Madrid, Spain

Faculty

Course Director:

Vincenzo Valentini, Radiotion Oncologist, Universita Cattolica S. Cuore, Rome (IT)

Teachers:
Regina Beets-Tan, Radiologist, University Hospital Maastricht (NL)
Joseph M. Borras, Epidemiologist, Cancer Plan, Department of Health, L'Hospitalet de Llobregat, Barcelona (ES)
Claudio Coco, Surgeon, Università Cattolica S.Cuore, Rome (IT)
Karin Haustermans, Radiation Oncologist, University Hospital Gasthuisberg, KU-Leuven (BE)
Corrie Marijnen, Radiation Oncologist, Nederlands Kanker Instituut, Amsterdam (NL)
Lars Pahlman, Surgeon, Uppsalal University Hospital (SE)
Claus Rödel, Radiation Oncologist, University Hospital Erlangen (DE)
Hans-Joachim Schmoll, Medical Oncologist, Martin Luther University Halle-Wittenberg (DE)
Nigel Scott, Pathologist, St James' University Hospital, Leeds (GB)
David Sebag-Montefiore, Clinical Oncologist, St James University Hospital, Leeds (GB)
Cornelis Van De Velde, Surgeon, Leiden University Medical Center (NL)

Aim of the course

This course, jointly organized by ESTRO, ESSO and ESMO seeks to promote an integrated approach between all specialists involved in rectal cancer to tailor the best treatment for each individual patient. The most relevant ongoing questions in multidisciplinary management of rectal cancer patients will be addressed in open debates and interaction with experts. In a truly multidisciplinary atmosphere, you will be able to identify the major uncertainties of your daily practice and learn how to handle them. You will have the opportunity to design a new research, starting from available state of the art evidences.The presence of colleagues with different specialties, from all over the world, will enrich your perspective and your daily practice. Don't miss this chance to encounter the best science in rectal cancer patients' management.

Target Group

The target group consists of surgeons, radiotherapists and medicals oncologists involved in the multidisciplinary treatment of rectal cancer.

Educational Programme

Day 1

• What we consider state of art in rectal cancer by ESSO, ESMO, and ESTRO
• The house believes that mesorectal fascia involvement requires tailored treatment: case presentation & case discussion
• Workshops
  

Day 2

• The house believes that nodal status is not detectable by imaging: case presentation & case discussion
  
• Workshops
  
• The house believes that laparoscopy surgery is a new gold standard: case presentation & case discussion
• The house believes no surgery in responders patients is reliable: case presentation & case discussion

Day 3

• Workshops
• The house believes that (neo) adjuvant therapy options can be adapted to the response along the treatment course: case presentations & case discussion
• The house believes that synchronous metastatic patients can be cured: case presentations & case discussion
• Working group on ‘New proposal for randomized studies’

Day 4

• The house believes that population based data are more relevant than randomized studies: case presentations & case discussion
  
• General debate on ‘New proposal for randomized studies

Registration
Please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it